Carnot CALYM
The Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field
The CALYM Carnot Institute fosters together 20 research teams specialized in lymphoma, first blood cancer. This academic consortium, without international equivalent, aims at accelerating innovation and its transfer in the lymphoma treatment and diagnosis through a unique R&D offer spanning from the identification of new biological targets to registration clinical trials.
Key figures
Fermer
Key figures
| Permanent staff (full-time equivalent) | 337 |
| PhD Students | 58 |
| Global budget | 32 M€ |
| Partnership incomes with industry | 28,2 M€ |
Contact
Fermer
Contact
institut Carnot CALYM
Centre Hospitalier Lyon-Sud
69495 Pierre-Bénite Cedex
Bertrand NADEL
Director
+33(0)7 63 79 13 40
bertrand.nadel[a]calym.org
Parent institutions
Fermer
Parent institutions
- AIX-MARSEILLE UNIVERSITÉ
- AP-HP ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
- CENTRE HENRI BECQUEREL
- CENTRE LÉON BÉRARD
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- CHU DE MONTPELLIER
- CHU DE NANTES
- CHU DE RENNES
- CHU DE TOULOUSE
- EFS BRETAGNE
- HOSPICES CIVILS DE LYON
- INSERM
- INSTITUT CLAUDIUS REGAUD - INSTITUT UNIVERSITAIRE DU CANCER TOULOUSE - ONCOPOLE
- INSTITUT GUSTAVE ROUSSY
- INSTITUT NECKER
- INSTITUT PAOLI-CALMETTES
- IRCCS
- LYSA
- LYSARC
- UNIVERSITÉ CLAUDE BERNARD LYON 1
- UNIVERSITÉ DE NICE SOPHIA ANTIPOLIS
- UNIVERSITÉ DE LIMOGES
- UNIVERSITÉ DE MONTPELLIER
- UNIVERSITÉ DE RENNES 1
- UNIVERSITÉ DE ROUEN NORMANDIE
- UNIVERSITÉ PARIS DESCARTES
- UNIVERSITÉ PARIS SUD
- UNIVERSITÉ PARIS-EST CRÉTEIL
- UNIVERSITÉ TOULOUSE 3
